echoloc

Prothya Biosolutions Tech Stack

Plasma fractionation and protein therapy manufacturing at scale

Pharmaceutical Manufacturing Neder-Over-Heembeek, Brussels 1,001–5,000 employees Founded 2021 Privately Held

Prothya processes ~3 million liters of plasma annually into clotting factors, immunoglobulins, and albumin for pharma partners. The tech stack—SAP, Siemens Step 7, Ignition SCADA, MES, Power BI—reflects a capital-intensive, regulated operation; the hiring profile (manufacturing and engineering dominance, quality specialists, leadership gaps in data) and active projects (IT/OT automation, utility validation, capacity increases) signal a manufacturing org modernizing its control systems and pushing volume while wrestling with GMP compliance, CSV (Computerized System Validation) rigor, and data quality across production.

Tech Stack 17 technologies

Core StackSAP Power BI Siemens Step 7 TIA Portal Wonderware Ignition CMMS SAP PM PLC SCADA DCS HMI Teams SAP WM Microsoft Office Minitab MES

What Prothya Biosolutions Is Building

Challenges

  • Maintaining compliance with gmp standards
  • Continuous improvement of csv processes
  • Out-of-specification results
  • Ensuring compliance with regulatory standards
  • Maintaining data quality in production and supply chain
  • Process optimization and efficiency improvements
  • Non-conformances
  • Deviations
  • Balance compliance and operational excellence
  • Downtime reduction

Active Projects

  • Improvement projects focused on efficiency, sustainability and cost reduction
  • Validation and qualification activities for utility systems
  • It/ot automation projects
  • Product quality review program
  • Capex projects
  • Capacity increase
  • Spare parts strategy
  • Digitizing hr processes
  • Developing hr dashboards
  • Implementing hr content updates

Hiring Activity

Accelerating45 roles · 25 in 30d

Department

Manufacturing
17
Engineering
9
Quality
8
Ops
5
HR
4
Data
2
Logistics
2

Seniority

Senior
18
Mid
13
Junior
6
Manager
4
Intern
3
Director
2
Lead
1

Notable leadership hires: Project Lead Engineering, Quality Director

Company intelligence

Find more companies like Prothya Biosolutions by tech stack, pain points and active projects

Get started free

About Prothya Biosolutions

Prothya Biosolutions is a plasma-derived medicine manufacturer formed in 2021 from the integration of Plasma Industries Belgium (with roots in the Belgian Red Cross) and Sanquin Plasma Products. The company operates a collection and fractionation facility in Brussels, converting human plasma into therapeutic proteins for pharmaceutical partners across multiple countries. Annual throughput is approximately 3 million liters. The product portfolio covers stable plasma derivatives—clotting factors, immunoglobulins, albumin solutions—alongside emerging protein therapy research. Operations span Belgium, Netherlands, and Canada; the organization is structured around manufacturing, engineering, quality assurance, and supply chain functions.

HeadquartersNeder-Over-Heembeek, Brussels
Company Size1,001–5,000 employees
Founded2021
Hiring MarketsNetherlands, Belgium, Canada

Frequently Asked Questions

What technology does Prothya Biosolutions use in manufacturing?

Core stack includes SAP (ERP), Siemens Step 7 and TIA Portal (PLC/automation), Wonderware and Ignition (SCADA/HMI), MES, Power BI (analytics), and Minitab (quality). These tools manage plasma processing, fractionation, and regulatory compliance.

Where is Prothya Biosolutions headquartered?

Neder-Over-Heembeek, Brussels, Belgium. Additional hiring footprint in Netherlands and Canada. Founded 2021; 1,001–5,000 employees.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size